Carlson Investments SE: Nutrix AG Advances Toward Launch of cortiSense – Award-Winning Cortisol Monitoring Technology

Carlson Investments SE announces that its healthtech portfolio company, Nutrix AG, is moving toward the market launch of cortiSense, a non-invasive, lab-grade cortisol monitoring sensor and CES Innovation Award 2025 winner. The device, integrated with Nutrix’s gSense platform, is designed to provide real-time hormonal insights to support preventive health and chronic disease management.

Warsaw/Monaco , 05 Aug 2025 (Viralpressreleases.com) - Carlson Investments SE announces that its healthtech portfolio company, Nutrix AG, is progressing toward the launch of cortiSense, a non-invasive, lab-grade cortisol monitoring sensor. The device recently won the CES Innovation Award 2025 in the Digital Health category, marking a new milestone in at-home hormone testing. Integrated with Nutrix’s gSense healthcare platform, cortiSense is designed to provide users with real-time hormonal data to support preventive healt

 

h and chronic disease management. 

Use of Proceeds and Development Plans

With the support of Carlson Investments SE and other strategic investors, Nutrix AG has raised USD 4 million to date. The company is advancing the commercialization of cortiSense and expanding its presence in international markets. Nutrix currently holds operational presence in Switzerland, Poland, Chile, Mexico, and Peru, with plans for further expansion into the U.S. and Japanese markets.

Current development efforts are focused on:

  • Scaling production  capabilities for cortiSense to prepare for market introduction;
  • Integrating cortiSense with the gSense platform to combine hormonal data with glucose, diet, and body composition information;

  • Continuing research into the role of cortisol in metabolic, mental, and women’s health.

About Nutrix AG

Nutrix AG is a Swiss healthcare company developing AI-based solutions for non-invasive health monitoring. Originally focused on glucose detection in saliva to support diabetes management, Nutrix aims to help users prevent and manage chronic conditions through accessible, painless tracking methods.

About Carlson Investments SE

Carlson Investments SE, listed on Warsaw’s NewConnect and the German Open Market (Frankfurt, Munich, Stuttgart, Gettex), supports high-growth early-stage tech ventures across healthtech, AI, fintech, and deeptech. Carlson applies a hands-on investment approach and integrates its portfolio companies into a global network of strategic partnerships.

Risk Disclaimer

This announcement • does not constitute investment advice or a solicitation to buy or sell financial instruments • involves risks, including possible loss of capital • does not guarantee future earnings • past performance is not indicative of future results.

WE ARE PUBLICLY LISTED, YOU CAN BUY OUR SHARES ON:

Warsaw Stock Exchange (PLN):   CAI, PLHOTB000011

Frankfurt Stock Exchange (EUR):   2HB (FRA), PLHOTB000011

Munich Stock Exchange (EUR):   2HB (MUN), PLHOTB000011

Stuttgart Stock Exchange (EUR):   2HB (STU), PLHOTB000011

GETTEX Exchange (EUR):   2HB (GET), PLHOTB000011

WKN:   A0RNWQ

 

Carlson Investments SE supports high-growth early-stage tech ventures across healthtech, AI, fintech, and deeptech. Carlson applies a hands-on investment approach and integrates its portfolio companies into a global network of strategic partnerships.

Media Contacts

Press Contact:

Management Office

Carlson Investments SE

ir@carlsonvc.com

 

carlsonvc.com/

Category : Business, Finance, Employment & Investment

Tags : Healthtech, Venture Capital, Startups,

###

Disclaimer

Disclaimer

All the content in published press releases at Viral Press Releases is written and submitted by the press release author.

Viral Press Releases DO NOT accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in any published press release on viralpressreleases.com

If you have any question regarding some information in a press release, please contact the person listed in 'Media Contacts ' at the bottom of press release page.

Please DO NOT attempt to contact Viral Press Releases. We will be unable to assist you with any information regarding any published press release on Viral Press Releases.

Viral Press Releases disclaims any content contained in any published press release on Viral Press Releases.